Skip to main content
. 2022 May 29;12(10):4629–4655. doi: 10.7150/thno.72465

Figure 17.

Figure 17

(A) Schematic Illustration of Combined PDT and Immunotherapy by IND@RAL for Combating Cancer. (B) Immunofluorescence imaging of CRT expression and HMGB1 release treated with RAL in the presence or absence of laser irradiation. (C) Flow cytometric analysis of CD3 and CD8, CD3 and CD4 positive cytotoxic T lymphocyte in spleen. Adapted with permission from 105, copyright 2019 American Chemical Society.